Clinical Trials on Solid Tumor, Unspecified, Adult

Total 5494 results

Vion Pharmaceuticals

Completed

3-AP in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Cancer Research UK

Completed

Geldanamycin Analogue in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

T138067 Sodium in Treating Patients With Advanced Refractory Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Polyglutamate Camptothecin in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Unknown

Oxaliplatin and Paclitaxel in Treating Patients With Metastatic or Unresectable Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Fox Chase Cancer Center
National Cancer Institute (NCI)

Completed

Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Combination Chemotherapy In Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Sirius Medicine

Completed

Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Jewish General Hospital
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
National Cancer Institute (NCI)

Completed

17-N-Allylamino-17-Demethoxygeldanamycin and Paclitaxel in Treating Patients With Metastatic or Unresectable Solid Tumor

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants (IRB 2004-535)

Unspecified Adult Solid Tumor, Protocol Specific

United States, United Kingdom
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Etoposide and Celecoxib in Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

BMS-599626 in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Astex Pharmaceuticals, Inc.

Completed

Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

Unspecified Adult Solid Tumor, Protocol Specific

United States
European Organisation for Research and Treatment...

Completed

Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care

Unspecified Adult Solid Tumor, Protocol Specific

France, United Kingdom, Belgium, Spain, Sweden
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Completed

Study of Hair Samples From Patients With Cancer

Unspecified Adult Solid Tumor, Protocol Specific
Georgetown University
National Cancer Institute (NCI)

Completed

Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

SU5416 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

SU5416 and Paclitaxel in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

BMS-214662 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)

Unknown

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

Unspecified Adult Solid Tumor, Protocol Specific
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Withdrawn

Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer

Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Hematopoietic/Lymphoid Cancer

United States
Ulrik Lassen

Recruiting

Copenhagen Prospective Personalized Oncology (CoPPO) (CoPPO)

Unspecified Adult Solid Tumor, Protocol Specific

Denmark
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for Cancer (NCI 8076)

Unspecified Adult Solid Tumor, Protocol Specific

Canada
Case Comprehensive Cancer Center

Completed

FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Perifosine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Montefiore Medical Center
National Cancer Institute (NCI)

Completed

Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Genzyme, a Sanofi Company

Completed

SR-45023A in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Chicago
National Cancer Institute (NCI)

Terminated

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Unspecified Adult Solid Tumor, Protocol Specific

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
R-Pharm
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center

Completed

BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Paclitaxel in Treating Older Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Surrey

Completed

Selenium in the Prevention of Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
National Cancer Institute (NCI)

Completed

Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

KRN5500 in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Terminated

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials

Unspecified Adult Solid Tumor, Protocol Specific

United States
SRI International
National Cancer Institute (NCI)

Completed

Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Josephine Ford Cancer Center
National Cancer Institute (NCI)

Unknown

Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations

Unspecified Adult Solid Tumor, Protocol Specific

United States

Clinical Trials on Solid Tumor, Unspecified, Adult

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations